Inhibition of Src kinase with the dual Src/AbI kinase inhibitor AZD0530 reduces bladder tumour growth and the development of mixed osteolytic/osteosclerotic lesions in bone

Inhibition of Src kinase with the dual Src/AbI kinase inhibitor AZD0530 reduces bladder tumour growth and the development of mixed osteolytic/osteosclerotic lesions in bone

Publication Details

Journal
Figshare
Published
2025-07-23
Primary Topic
Protein Kinase Regulation and GTPase Signaling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Inhibition of Src kinase with the dual Src/AbI kinase inhibitor AZD0530 reduces bladder tumour growth and the development of mixed osteolytic/osteosclerotic lesions in bone

Figshare
Protein Kinase Regulation and GTPase Signaling
article

Inhibition of Src kinase with the dual Src/AbI kinase inhibitor AZD0530 reduces bladder tumour growth and the development of mixed osteolytic/osteosclerotic lesions in bone

article en

Abstract

Inhibition of Src kinase with the dual Src/AbI kinase inhibitor AZD0530 reduces bladder tumour growth and the development of mixed osteolytic/osteosclerotic lesions in bone

Figshare
Openalex Percentile: Top 50%
Protein Kinase Regulation and GTPase Signaling
OpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Inhibition of Src kinase with the dual Src/AbI kinase inhibitor AZD0530 reduces bladder tumour growth and the development of mixed osteolytic/osteosclerotic lesions in bone · Figshare (2025) | TGRS Research Map | TGRS